Skip to main content

Want a detailed portfolio tracker?

Metagenomi (MGX) P/E (2024 - 2026)

Metagenomi (MGX) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Metagenomi (MGX) P/E is -0.53. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Metagenomi (MGX)

YearP/EChange
2026-0.53-22.80%
2025-0.69-60.06%
2024-1.73N/A

Comparison Metagenomi (MGX) P/E with competitors

Metagenomi (MGX) P/E is -0.53.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.32%
NBYStablecoin Development Corp0.00-100.81%
ENLVEnlivex Ltd0.07-114.01%
FGENFibroGen Inc0.24-144.96%
CHRSCoherus Biosciences Inc0.85-258.91%
FBIOFortress Biotech Inc0.95-277.74%
ORMPOramed Pharmaceuticals Inc1.50-381.50%
AGENAgenus Inc3.01-663.65%
INVAInnoviva Inc3.15-690.69%
VXRTVaxart Inc3.55-764.80%
CRMDCorMedix Inc3.63-779.54%
CVACCureVac N.V.4.45-932.59%
GLPGGalapagos NV4.86-1009.98%
SRPTSarepta Therapeutics Inc4.88-1014.33%
ABEOAbeona Therapeutics Inc5.39-1108.98%
ABUSArbutus Biopharma Corp5.60-1147.96%
ZVRAZevra Therapeutics Inc5.89-1202.57%
SPROSpero Therapeutics Inc6.23-1266.47%
CGENCompugen Ltd6.31-1282.49%
RIGLRigel Pharmaceuticals6.87-1387.01%
SLXNSilexion Therapeutics Corp7.30-1466.42%
OMEROmeros Corporation9.26-1834.00%
AUPHAurinia Pharmaceuticals Inc9.58-1895.09%
PLXProtalix BioTherapeutics Inc10.89-2139.69%
ACADAcadia Pharmaceuticals Inc11.73-2296.54%
TBPHTheravance Biopharma Inc12.26-2396.48%
ADMAAdma Biologics Inc12.42-2425.70%
HRMYHarmony Biosciences Holdings Inc13.82-2688.28%
SABSSAB Biotherapeutics Inc14.14-2747.46%
NAGENiagen Bioscience Inc14.82-2875.17%
INCYIncyte Corp15.82-3063.29%
REGNRegeneron Pharmaceuticals Inc15.86-3069.67%
PBYIPuma Biotechnology Inc17.32-3342.93%
CPRXCatalyst Pharmaceuticals Inc17.44-3366.08%
EXELExelixis Inc17.54-3384.56%
TGTXTG Therapeutics Inc18.97-3652.01%
MDXGMimedx Group Inc20.55-3949.12%
XOMAXOMA Royalty Corp22.87-4384.14%
ARGXArgen X SE24.30-4650.71%
CTMXCytomX Therapeutics Inc24.82-4748.68%
XOMAOXOMA Royalty Corp25.34-4846.76%
HALOHalozyme Therapeutics Inc25.62-4899.00%
XOMAPXOMA Royalty Corp25.67-4907.69%
VRTXVertex Pharmaceuticals Inc27.99-5343.06%
RPRXRoyalty Pharma plc - Class A28.69-5472.81%
SLNOSoleno Therapeutics Inc29.02-5534.21%
ASNDAscendis Pharma A/S30.09-5734.64%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7200.44%
APLSApellis Pharmaceuticals Inc39.02-7408.18%
BMRNBiomarin Pharmaceutical Inc42.21-8005.75%
KRYSKrystal Biotech Inc45.34-8592.26%
ONCBeiGene Ltd69.54-13124.05%
PHARPharming Group N.V.75.03-14151.35%
TECHBio-Techne Corp101.96-19195.53%
VCELVericel Corp109.92-20686.89%
ALNYAlnylam Pharmaceuticals Inc117.96-22193.39%
GMABGenmab140.29-26374.71%
TLXTelix Pharmaceuticals Ltd162.15-30469.20%
CORTCorcept Therapeutics Inc212.86-39965.56%